R&D / revenue moved 39818 bp lower
R&D / revenue changed -39818 basis points from the comparable as-filed period.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
R&D / revenue changed -39818 basis points from the comparable as-filed period.
Free-cash-flow margin changed +45254 basis points from the comparable as-filed period.
Operating cash-flow margin changed +43050 basis points from the comparable as-filed period.
Receivables / revenue changed -2896 basis points from the comparable as-filed period.
Capital expenditure changed +11.4% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Working capital / assets changed +151 basis points from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Current ratio changed -12.2% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.